Interpace Biosciences, Inc.
IDXG
$0.765
$0.06499.27%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.88M | 6.94M | 6.09M | 4.20M | 2.31M |
| Total Depreciation and Amortization | 778.00K | 748.00K | 723.00K | 886.00K | 1.26M |
| Total Amortization of Deferred Charges | 11.00K | -- | 0.00 | 14.00K | 28.00K |
| Total Other Non-Cash Items | 740.00K | 872.00K | 1.06M | 999.00K | 1.36M |
| Change in Net Operating Assets | -3.47M | -3.92M | -3.27M | -2.51M | -2.36M |
| Cash from Operations | 5.94M | 4.65M | 4.60M | 3.59M | 2.60M |
| Capital Expenditure | -848.00K | -876.00K | -889.00K | -519.00K | -433.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 500.00K | 383.00K |
| Cash from Investing | -848.00K | -876.00K | -889.00K | -19.00K | -50.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -6.50M | -5.60M | -4.10M | -4.10M | -2.80M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -46.00K | -46.00K | -32.00K | -32.00K | -32.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -161.00K | -161.00K | -2.50M | -2.50M | -2.50M |
| Cash from Financing | -6.71M | -5.81M | -6.63M | -6.63M | -5.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.62M | -2.04M | -2.92M | -3.06M | -2.78M |